Nerve pain can occur alone in a particular antibody-associated disease
A case report and review describe pain patterns and treatment responses in a specific immune-related condition, without establishing which treatment works best.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review describes severe nerve pain in patients with a particular antibody-associated disease, including uncommon cases where pain was the only clinical feature. Pain improvement was reported after immune-directed and symptom-focused treatments. However, these reports do not establish comparative effectiveness or show that people with nerve pain generally have this condition.
This abstract-based account reports treatment outcomes from different patient subsets without describing a controlled comparison. Response definitions, assessment timing, and selection of patients for each treatment cannot be evaluated from the abstract.
Pain had several presentations
Descriptions included burning pain toward the ends of the limbs, widespread pain accompanied by muscle aches and cramps, and back pain spreading into the legs. Pain sometimes appeared without other clinical features of the antibody-associated disease.
Reported improvement is not a treatment ranking
The abstract describes improvement after immunotherapy and after treatments aimed at symptoms, using different patient groups. Comparing those response proportions directly would not establish which approach is better, because a controlled comparison is not described.
The original publication
Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review.
Cornacchini S, Verza MU, Schiavolin M et al.
J Neuroimmunol · 2025
- PubMed ID
- 40885133
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.